Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trustar Capital
Hong Kong, Hong Kongtrustarcapital.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Trustar Capital (formerly known as CITIC Capital Partners) is a leading private equity firm and an affiliate of CITIC Capital Holdings Limited. Headquartered in Hong Kong, the firm focuses on control buyout opportunities globally, particularly in companies that can capitalize on the growth and productivity of the Chinese economy. Trustar Capital has a significant investment footprint in the healthcare and life sciences sectors, with a portfolio that includes Harbin Pharmaceutical Group, GNC, Taibang Biologic Group, Jissbon, Genertec Universal Medical, Hygeia Healthcare, Genesis MedTech, MedAlliance, and Guilong Pharmaceutical. The firm manages billions in committed capital across multiple funds, driving value creation through strategic M&A and operational integration.
- Industry
- Investors
Beyond the preview
Go deeper on Trustar Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trustar Capital.